N

Neurana Pharmaceuticals

2 employees

Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

2013

Funding rounds raised

Total raised

$60M

from 4 investors over 4 rounds

N

Neurana Pharmaceuticals raised $60M on May 8, 2018

Investors: H.I.G. BioVentures, New Leaf Venture Partners, Sofinnova Ventures, Russia technology fund and Longitude Capital

FAQ